Ownership history in CM Management, LLC · 20 quarters on record
This page tracks every 13F SEC filing in which CM Management, LLC reported a position in ELEDON PHARMACEUTICALS INC (ELDN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 650,000 | +50,000 | +8.3% | 0.83% | $982K | $1.51 |
| 2025 Q3 | ADDED | 600,000 | +225,000 | +60.0% | 1.30% | $1.6M | $2.59 |
| 2025 Q2 | ADDED | 375,000 | +100,000 | +36.4% | 0.93% | $1.0M | $2.71 |
| 2025 Q1 | UNCHANGED | 275,000 | — | 0% | 0.94% | $932K | $3.39 |
| 2024 Q4 | UNCHANGED | 275,000 | — | 0% | 1.01% | $1.1M | $4.12 |
| 2024 Q3 | ADDED | 275,000 | +115,000 | +71.9% | 0.55% | $685K | $2.49 |
| 2024 Q2 | UNCHANGED | 160,000 | — | 0% | 0.39% | $422K | $2.64 |
| 2024 Q1 | ADDED | 160,000 | +20,000 | +14.3% | 0.28% | $330K | $2.06 |
| 2023 Q4 | REDUCED | 140,000 | -94,803 | -40.4% | 0.20% | $252K | $1.80 |
| 2023 Q3 | UNCHANGED | 234,803 | — | 0% | 0.34% | $322K | $1.37 |
As of 2025 Q4 — sorted by position size